List of Tables
Table 1. Motion Sickness Medicine Market Trends
Table 2. Motion Sickness Medicine Market Drivers & Opportunity
Table 3. Motion Sickness Medicine Market Challenges
Table 4. Motion Sickness Medicine Market Restraints
Table 5. Global Motion Sickness Medicine Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Motion Sickness Medicine Revenue Market Share by Company (2019-2024)
Table 7. Global Motion Sickness Medicine Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Motion Sickness Medicine Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Motion Sickness Medicine Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Motion Sickness Medicine Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Motion Sickness Medicine Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Motion Sickness Medicine
Table 13. Global Motion Sickness Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Motion Sickness Medicine as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Motion Sickness Medicine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Motion Sickness Medicine Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Motion Sickness Medicine Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Motion Sickness Medicine Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Motion Sickness Medicine Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Motion Sickness Medicine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Motion Sickness Medicine Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Motion Sickness Medicine Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Motion Sickness Medicine Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Motion Sickness Medicine Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Motion Sickness Medicine Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Motion Sickness Medicine Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Motion Sickness Medicine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Motion Sickness Medicine Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Motion Sickness Medicine Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Motion Sickness Medicine Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Motion Sickness Medicine Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Motion Sickness Medicine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Motion Sickness Medicine Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Motion Sickness Medicine Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Motion Sickness Medicine Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Motion Sickness Medicine Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Motion Sickness Medicine Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Motion Sickness Medicine Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Motion Sickness Medicine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Motion Sickness Medicine Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Motion Sickness Medicine Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Motion Sickness Medicine Sales Value by Region (2019-2024) & (%)
Table 44. Global Motion Sickness Medicine Sales Value by Region (2025-2030) & (%)
Table 45. Global Motion Sickness Medicine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Motion Sickness Medicine Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Motion Sickness Medicine Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Motion Sickness Medicine Sales Volume by Region (2019-2024) & (%)
Table 49. Global Motion Sickness Medicine Sales Volume by Region (2025-2030) & (%)
Table 50. Global Motion Sickness Medicine Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Motion Sickness Medicine Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Motion Sickness Medicine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Motion Sickness Medicine Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Motion Sickness Medicine Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Motion Sickness Medicine Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Motion Sickness Medicine Sales Volume, (2025-2030) & (K Units)
Table 57. Dramamine Company Information
Table 58. Dramamine Introduction and Business Overview
Table 59. Dramamine Motion Sickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Dramamine Motion Sickness Medicine Product Offerings
Table 61. Dramamine Recent Development
Table 62. Avomine Company Information
Table 63. Avomine Introduction and Business Overview
Table 64. Avomine Motion Sickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Avomine Motion Sickness Medicine Product Offerings
Table 66. Avomine Recent Development
Table 67. Cinnarizine Company Information
Table 68. Cinnarizine Introduction and Business Overview
Table 69. Cinnarizine Motion Sickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Cinnarizine Motion Sickness Medicine Product Offerings
Table 71. Cinnarizine Recent Development
Table 72. Kwells Company Information
Table 73. Kwells Introduction and Business Overview
Table 74. Kwells Motion Sickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Kwells Motion Sickness Medicine Product Offerings
Table 76. Kwells Recent Development
Table 77. Tummydrops Company Information
Table 78. Tummydrops Introduction and Business Overview
Table 79. Tummydrops Motion Sickness Medicine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Tummydrops Motion Sickness Medicine Product Offerings
Table 81. Tummydrops Recent Development
Table 82. Key Raw Materials Lists
Table 83. Raw Materials Key Suppliers Lists
Table 84. Motion Sickness Medicine Downstream Customers
Table 85. Motion Sickness Medicine Distributors List
Table 86. Research Programs/Design for This Report
Table 87. Key Data Information from Secondary Sources
Table 88. Key Data Information from Primary Sources
List of Figures
Figure 1. Motion Sickness Medicine Product Picture
Figure 2. Global Motion Sickness Medicine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Motion Sickness Medicine Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Motion Sickness Medicine Sales Volume (2019-2030) & (K Units)
Figure 5. Global Motion Sickness Medicine Sales Price (2019-2030) & (US$/Unit)
Figure 6. Motion Sickness Medicine Report Years Considered
Figure 7. Global Motion Sickness Medicine Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Motion Sickness Medicine Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Motion Sickness Medicine Revenue in 2023
Figure 10. Motion Sickness Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Drops Picture
Figure 12. Capsule Picture
Figure 13. Tablet Picture
Figure 14. Global Motion Sickness Medicine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Motion Sickness Medicine Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Motion Sickness Medicine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Motion Sickness Medicine Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Motion Sickness Medicine Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Vehicle
Figure 20. Product Picture of Boat
Figure 21. Product Picture of Airplane
Figure 22. Product Picture of Others
Figure 23. Global Motion Sickness Medicine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 24. Global Motion Sickness Medicine Sales Value Market Share by Application, 2023 & 2030
Figure 25. Global Motion Sickness Medicine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 26. Global Motion Sickness Medicine Sales Volume Market Share by Application, 2023 & 2030
Figure 27. Global Motion Sickness Medicine Price by Application (2019-2030) & (US$/Unit)
Figure 28. North America Motion Sickness Medicine Sales Value (2019-2030) & (US$ Million)
Figure 29. North America Motion Sickness Medicine Sales Value by Country (%), 2023 VS 2030
Figure 30. Europe Motion Sickness Medicine Sales Value (2019-2030) & (US$ Million)
Figure 31. Europe Motion Sickness Medicine Sales Value by Country (%), 2023 VS 2030
Figure 32. Asia Pacific Motion Sickness Medicine Sales Value (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Motion Sickness Medicine Sales Value by Country (%), 2023 VS 2030
Figure 34. South America Motion Sickness Medicine Sales Value (2019-2030) & (US$ Million)
Figure 35. South America Motion Sickness Medicine Sales Value by Country (%), 2023 VS 2030
Figure 36. Middle East & Africa Motion Sickness Medicine Sales Value (2019-2030) & (US$ Million)
Figure 37. Middle East & Africa Motion Sickness Medicine Sales Value by Country (%), 2023 VS 2030
Figure 38. Key Countries/Regions Motion Sickness Medicine Sales Value (%), (2019-2030)
Figure 39. Key Countries/Regions Motion Sickness Medicine Sales Volume (%), (2019-2030)
Figure 40. United States Motion Sickness Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 41. United States Motion Sickness Medicine Sales Value by Type (%), 2023 VS 2030
Figure 42. United States Motion Sickness Medicine Sales Value by Application (%), 2023 VS 2030
Figure 43. Europe Motion Sickness Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 44. Europe Motion Sickness Medicine Sales Value by Type (%), 2023 VS 2030
Figure 45. Europe Motion Sickness Medicine Sales Value by Application (%), 2023 VS 2030
Figure 46. China Motion Sickness Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 47. China Motion Sickness Medicine Sales Value by Type (%), 2023 VS 2030
Figure 48. China Motion Sickness Medicine Sales Value by Application (%), 2023 VS 2030
Figure 49. Japan Motion Sickness Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 50. Japan Motion Sickness Medicine Sales Value by Type (%), 2023 VS 2030
Figure 51. Japan Motion Sickness Medicine Sales Value by Application (%), 2023 VS 2030
Figure 52. South Korea Motion Sickness Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 53. South Korea Motion Sickness Medicine Sales Value by Type (%), 2023 VS 2030
Figure 54. South Korea Motion Sickness Medicine Sales Value by Application (%), 2023 VS 2030
Figure 55. Southeast Asia Motion Sickness Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 56. Southeast Asia Motion Sickness Medicine Sales Value by Type (%), 2023 VS 2030
Figure 57. Southeast Asia Motion Sickness Medicine Sales Value by Application (%), 2023 VS 2030
Figure 58. India Motion Sickness Medicine Sales Value, (2019-2030) & (US$ Million)
Figure 59. India Motion Sickness Medicine Sales Value by Type (%), 2023 VS 2030
Figure 60. India Motion Sickness Medicine Sales Value by Application (%), 2023 VS 2030
Figure 61. Motion Sickness Medicine Industrial Chain
Figure 62. Motion Sickness Medicine Manufacturing Cost Structure
Figure 63. Channels of Distribution (Direct Sales, and Distribution)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed